MARKET

IMUX

IMUX

Immunic Inc
NASDAQ
1.370
-0.100
-6.80%
Pre Market: 1.310 -0.06 -4.38% 04:24 09/22 EDT
OPEN
1.410
PREV CLOSE
1.470
HIGH
1.430
LOW
1.360
VOLUME
3.00K
TURNOVER
--
52 WEEK HIGH
11.76
52 WEEK LOW
1.110
MARKET CAP
61.10M
P/E (TTM)
-0.4167
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at IMUX last week (0911-0915)?
Weekly Report · 4d ago
Weekly Report: what happened at IMUX last week (0904-0908)?
Weekly Report · 09/11 09:20
Weekly Report: what happened at IMUX last week (0828-0901)?
Weekly Report · 09/04 11:38
Weekly Report: what happened at IMUX last week (0821-0825)?
Weekly Report · 08/28 09:21
Immunic Inc: Securities to be offered to employees in employee benefit plans
Press release · 08/21 12:02
Weekly Report: what happened at IMUX last week (0814-0818)?
Weekly Report · 08/21 11:07
Insider Returns Down To US$35k As Immunic's Stock Dips 12%
Simply Wall St · 08/19 14:34
Wedbush Sticks to Its Buy Rating for Immunic (IMUX)
TipRanks · 08/04 10:55
More
About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. It is engaged in the clinical development of three orally administered, small molecule programs to address the unmet needs of patients. These include the vidofludimus calcium (IMU-838) program, which is focused on the development of oral formulations of a small molecule inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH); the IMU-935 program, which is focused on an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated (RORyt), an immune cell-specific isoform of RORy; and the IMU-856 program, which involves the development of a drug targeting the restoration of intestinal barrier function and regeneration of bowel epithelium. These product candidates are being developed to address diseases such as multiple sclerosis (MS), psoriasis and gastrointestinal diseases.

Webull offers kinds of Immunic Inc stock information, including NASDAQ:IMUX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMUX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IMUX stock methods without spending real money on the virtual paper trading platform.